[1]
“Efficacy of potent topical corticosteroid (betamethasone valerate 0.1%) compared with mild topical corticosteroid (hydrocortisone 1%) in the management of acute radiodermatitis”, J Pak Assoc Dermatol, vol. 16, no. 3, pp. 151–155, Jan. 2017, doi: 10.66344/jpad.16.3.2006.868.